Embeda's Proposed Epidemiological Study Program
You may also be interested in...
Purdue NDA For Oxycodone/Naloxone Combo Tests New FDA Policy
The sponsor believes its data package could support a labeling claim that the drug “is expected to result in a meaningful reduction in abuse”; the agency’s review could indicate the strength of data needed to support such a claim.
Purdue NDA For Oxycodone/Naloxone Combo Tests New FDA Policy
The sponsor believes its data package could support a labeling claim that the drug “is expected to result in a meaningful reduction in abuse”; the agency’s review could indicate the strength of data needed to support such a claim.
Pfizer Will Study Oxecta Abuse/Misuse Potential Post-Market
FDA okays the opioid, which contains abuse-resistant components, with labeling about a study that found the drug less likeable than immediate-release oxycodone.